Search results: Sage Journals

Retricted accessResearch articleFirst published October, 2024

Analysis of composite time-to-event endpoints in cardiovascular outcome trials

Rachel Marceau West, Gregory Golm, Devan V Mehrotra

Clinical Trials

Retricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Open accessResearch articleFirst published 2019

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Cameron M. Kieffer, Andrew S. Robertson

Therapeutic Innovation & Regulatory Science

Open accessResearch articleFirst published July, 2013

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial

Julio Rosenstock, Nikolaus Marx, Steven E Kahn [...]

Diabetes & Vascular Disease Research

Open accessResearch articleFirst published May, 2015

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA ® )

Nikolaus Marx, Julio Rosenstock, Steven E Kahn [...]

Diabetes & Vascular Disease Research

Retricted accessResearch articleFirst published February, 2019

Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial

Armin Attar, Mehrab Sayadi, Mansoor Jannati

European Journal of Preventive Cardiology

Open accessResearch articleFirst published March, 2015

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

Silvio E Inzucchi, Bernard Zinman, Christoph Wanner [...]

Diabetes & Vascular Disease Research

Retricted accessResearch articleFirst published August, 2019

Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health

Qinli Ma, Haechung Chung, Sonali Shambhu [...]

Clinical Trials

Open accessResearch articleFirst published May, 2026

Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in chronic obstructive pulmonary disease: A systematic review,meta-analysis,and trial sequential analysis of randomized controlled trials

Chih-Chung Lin, Hui-Lin Sung, Po-Yu Huang [...]

Journal of International Medical Research

Open accessResearch articleFirst published July, 2020

Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey

Nathan D Wong, Wenjun Fan, Jonathan Pak

Diabetes & Vascular Disease Research

Retricted accessResearch articleFirst published October, 2024

Analysis of composite time-to-event endpoints in cardiovascular outcome trials

Rachel Marceau West, Gregory Golm, Devan V Mehrotra

Clinical Trials

Retricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Open accessResearch articleFirst published 2019

Impact of FDA-Required Cardiovascular Outcome Trials on Type 2 Diabetes Clinical Study Initiation From 2008 to 2017

Cameron M. Kieffer, Andrew S. Robertson

Therapeutic Innovation & Regulatory Science

Open accessResearch articleFirst published July, 2013

Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial

Julio Rosenstock, Nikolaus Marx, Steven E Kahn [...]

Diabetes & Vascular Disease Research

Open accessResearch articleFirst published May, 2015

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA ® )

Nikolaus Marx, Julio Rosenstock, Steven E Kahn [...]

Diabetes & Vascular Disease Research

Retricted accessResearch articleFirst published February, 2019

Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial

Armin Attar, Mehrab Sayadi, Mansoor Jannati

European Journal of Preventive Cardiology

Open accessResearch articleFirst published March, 2015

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

Silvio E Inzucchi, Bernard Zinman, Christoph Wanner [...]

Diabetes & Vascular Disease Research

Retricted accessResearch articleFirst published August, 2019

Administrative claims data to support pragmatic clinical trial outcome ascertainment on cardiovascular health

Qinli Ma, Haechung Chung, Sonali Shambhu [...]

Clinical Trials

Open accessResearch articleFirst published May, 2026

Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in chronic obstructive pulmonary disease: A systematic review,meta-analysis,and trial sequential analysis of randomized controlled trials

Chih-Chung Lin, Hui-Lin Sung, Po-Yu Huang [...]

Journal of International Medical Research

Open accessResearch articleFirst published July, 2020

Estimating the number of preventable cardiovascular disease events in the United States using the EMPA-REG OUTCOME trial results and National Health and Nutrition Examination Survey

Nathan D Wong, Wenjun Fan, Jonathan Pak

Diabetes & Vascular Disease Research